These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
170 related articles for article (PubMed ID: 15380867)
1. Differential effects of 5-HT1 and 5-HT2 receptor agonists on hindlimb movements in paraplegic mice. Landry ES; Guertin PA Prog Neuropsychopharmacol Biol Psychiatry; 2004 Sep; 28(6):1053-60. PubMed ID: 15380867 [TBL] [Abstract][Full Text] [Related]
2. Role of spinal 5-HT2 receptor subtypes in quipazine-induced hindlimb movements after a low-thoracic spinal cord transection. Ung RV; Landry ES; Rouleau P; Lapointe NP; Rouillard C; Guertin PA Eur J Neurosci; 2008 Dec; 28(11):2231-42. PubMed ID: 19019202 [TBL] [Abstract][Full Text] [Related]
3. Synergistic activation of the central pattern generator for locomotion by l-beta-3,4-dihydroxyphenylalanine and quipazine in adult paraplegic mice. Guertin PA Neurosci Lett; 2004 Mar; 358(2):71-4. PubMed ID: 15026151 [TBL] [Abstract][Full Text] [Related]
4. Ionotropic 5-HT3 receptor agonist-induced motor responses in the hindlimbs of paraplegic mice. Guertin PA; Steuer I J Neurophysiol; 2005 Nov; 94(5):3397-405. PubMed ID: 16049141 [TBL] [Abstract][Full Text] [Related]
5. Synergistic effects of D1/5 and 5-HT1A/7 receptor agonists on locomotor movement induction in complete spinal cord-transected mice. Lapointe NP; Guertin PA J Neurophysiol; 2008 Jul; 100(1):160-8. PubMed ID: 18480366 [TBL] [Abstract][Full Text] [Related]
6. Contribution of spinal 5-HT1A and 5-HT7 receptors to locomotor-like movement induced by 8-OH-DPAT in spinal cord-transected mice. Landry ES; Lapointe NP; Rouillard C; Levesque D; Hedlund PB; Guertin PA Eur J Neurosci; 2006 Jul; 24(2):535-46. PubMed ID: 16836640 [TBL] [Abstract][Full Text] [Related]
7. Tail pinching-induced hindlimb movements are suppressed by clonidine in spinal cord injured mice. Lapointe NP; Ung RV; Rouleau P; Guertin PA Behav Neurosci; 2008 Jun; 122(3):576-88. PubMed ID: 18513128 [TBL] [Abstract][Full Text] [Related]
8. Role of the 5-HT2C receptor in improving weight-supported stepping in adult rats spinalized as neonates. Kao T; Shumsky JS; Jacob-Vadakot S; Himes BT; Murray M; Moxon KA Brain Res; 2006 Sep; 1112(1):159-68. PubMed ID: 16914121 [TBL] [Abstract][Full Text] [Related]
9. Ejaculatory response induced by a 5-HT2 receptor agonist m-CPP in rats: differential roles of 5-HT2 receptor subtypes. Yonezawa A; Yoshizumi M; Ebiko M; Ise SN; Watanabe C; Mizoguchi H; Kimura Y; Sakurada S Pharmacol Biochem Behav; 2008 Feb; 88(4):367-73. PubMed ID: 17936345 [TBL] [Abstract][Full Text] [Related]
10. Effects of spinal alpha(2)-adrenoceptor and I(1)-imidazoline receptor activation on hindlimb movement induction in spinal cord-injured mice. Lapointe NP; Ung RV; Rouleau P; Guertin PA J Pharmacol Exp Ther; 2008 Jun; 325(3):994-1006. PubMed ID: 18364473 [TBL] [Abstract][Full Text] [Related]
11. Grafting of fetal brainstem 5-HT neurons into the sublesional spinal cord of paraplegic rats restores coordinated hindlimb locomotion. Sławińska U; Miazga K; Cabaj AM; Leszczyńska AN; Majczyński H; Nagy JI; Jordan LM Exp Neurol; 2013 Sep; 247():572-81. PubMed ID: 23481546 [TBL] [Abstract][Full Text] [Related]
12. Partial 5-HT(1A) receptor agonist activity by the 5-HT(2C) receptor antagonist SB 206,553 is revealed in rats spinalized as neonates. Shumsky JS; Kao T; Amato N; Simansky K; Murray M; Moxon KA Exp Neurol; 2005 Feb; 191(2):361-5. PubMed ID: 15649492 [TBL] [Abstract][Full Text] [Related]
13. Long-lasting recovery of locomotor function in chronic spinal rat following chronic combined pharmacological stimulation of serotonergic receptors with 8-OHDPAT and quipazine. Antri M; Barthe JY; Mouffle C; Orsal D Neurosci Lett; 2005 Aug 12-19; 384(1-2):162-7. PubMed ID: 15905027 [TBL] [Abstract][Full Text] [Related]
14. Intrathecal application of cyproheptadine impairs locomotion in intact rats. Majczyński H; Cabaj A; Górska T Neurosci Lett; 2005 Jun 10-17; 381(1-2):16-20. PubMed ID: 15882782 [TBL] [Abstract][Full Text] [Related]
15. Effects of mu-CPP and mesulergine on dietary choices in deprived rats: possible mechanisms of their action. Antonatos S; Galanopoulou P Prog Neuropsychopharmacol Biol Psychiatry; 2006 Jan; 30(1):112-9. PubMed ID: 16242827 [TBL] [Abstract][Full Text] [Related]
16. Vasoconstrictor responses to 5-hydroxytryptamine in the autoperfused hindquarters of spontaneously hypertensive rats. Calama E; Morán A; Ortiz de Urbina AV; Martín ML; San Román L Pharmacology; 2004 Jun; 71(2):66-72. PubMed ID: 15118345 [TBL] [Abstract][Full Text] [Related]
17. In vitro and in vivo characterization of F-97013-GD, a partial 5-HT1A agonist with antipsychotic- and antiparkinsonian-like properties. Zazpe A; Artaiz I; Innerárity A; Del Olmo E; Castro E; Labeaga L; Pazos A; Orjales A Neuropharmacology; 2006 Jul; 51(1):129-40. PubMed ID: 16643965 [TBL] [Abstract][Full Text] [Related]
18. L-DOPA and quipazine elicit air-stepping in neonatal rats with spinal cord transections. McEwen ML; Van Hartesveldt C; Stehouwer DJ Behav Neurosci; 1997 Aug; 111(4):825-33. PubMed ID: 9267660 [TBL] [Abstract][Full Text] [Related]
19. Effect of 1-(m-chlorophenyl)piperazine and 1-(m-trifluoromethylphenyl)piperazine on locomotor activity. Lucki I; Ward HR; Frazer A J Pharmacol Exp Ther; 1989 Apr; 249(1):155-64. PubMed ID: 2709329 [TBL] [Abstract][Full Text] [Related]
20. Combined 5-HT1A and 5-HT1B receptor agonists for the treatment of L-DOPA-induced dyskinesia. Muñoz A; Li Q; Gardoni F; Marcello E; Qin C; Carlsson T; Kirik D; Di Luca M; Björklund A; Bezard E; Carta M Brain; 2008 Dec; 131(Pt 12):3380-94. PubMed ID: 18952677 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]